Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of fenofibrate + pravastatin combination in high vascular risk patients with combined hyperlipidemia
2005-005185-36Phase 3Completed
- Sponsor
- SMB Laboratoires
- Start
- Jan 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of fenofibrate and pravastatin in combined dyslipidaemia, hypercholesterolemia, hypertriglyceridemia and 1 more, sponsored by SMB Laboratoires. Primary endpoint: Primary safety profile. Started Jan 2006; status: completed.
02
Drugs
fenofibratepravastatin
03
Conditions
combined dyslipidaemiahypercholesterolemiahypertriglyceridemiaVasculopathy
Beyond the preview
Go deeper on 2005-005185-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005185-36.